Live from the NIH registry
Studies recruiting near Colorado Springs right now
Top 25 of 203 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Ulcerative Colitis
Phase 2
Interventional 224 participants sought
Peak Gastroenterology Associates — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Genentech, Inc.
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Breast Cancer
Phase 3
Interventional 400 participants sought
Rocky Mountain Cancer Centers LLP — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Pfizer
A Study of Depemokimab in Participants of 6 to 11 Years of Age
Asthma
Phase 3
Interventional 34 participants sought
GSK Investigational Site — Colorado Springs, Colorado (4.0 mi)
· Sponsor: GlaxoSmithKline
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
UCHealth Memorial Hospital Central — Colorado Springs, Colorado (4.0 mi)
· Sponsor: SWOG Cancer Research Network
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Multiple conditions
N/A
Observational 2,900 participants sought
Penrose-Saint Francis Healthcare — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
Penrose-Saint Francis Healthcare — Colorado Springs, Colorado (4.0 mi)
· Sponsor: NRG Oncology
A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma
Neuroblastoma Recurrent
Phase 2
Interventional 54 participants sought
Children's Hospital of Colorado — Colorado Springs, Colorado (4.0 mi)
· Sponsor: St. Jude Children's Research Hospital
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Penrose-Saint Francis Healthcare — Colorado Springs, Colorado (4.0 mi)
· Sponsor: NRG Oncology
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
N/A
Interventional 9,500 participants sought
Penrose-Saint Francis Healthcare — Colorado Springs, Colorado (4.0 mi)
· Sponsor: NRG Oncology
Improving Maternal Sleep and Mental Health
Postpartum Depression, Postpartum Anxiety
N/A
Interventional 342 participants sought
University of Colorado Colorado Springs — Colorado Springs, Colorado (4.0 mi)
· Sponsor: University of Colorado, Colorado Springs
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Bipolar Disorder Type I With Mania
Phase 3
Interventional 450 participants sought
Local Institution - 0203 — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Bristol-Myers Squibb
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
Alzheimer's Disease
Phase 3
Interventional 586 participants sought
Research of the Rockies — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Bristol-Myers Squibb
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma
Phase 3
Interventional 1,295 participants sought
UCHealth Memorial Hospital Central — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Acute Migraine
Phase 3
Interventional 1,000 participants sought
MCB Clinical Research Centers — Colorado Springs, Colorado (4.0 mi)
· Sponsor: TriGemX Bio, Inc.
Improving Care for Rural Patients With Solid Tumors
Lung Cancer, Head and Neck Cancer
N/A
Interventional 320 participants sought
Memorial Hospital Central — Colorado Springs, Colorado (4.0 mi)
· Sponsor: University of Colorado, Denver
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Hoffmann-La Roche
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Akero Therapeutics, Inc
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
UCHealth Memorial Hospital Central — Colorado Springs, Colorado (4.0 mi)
· Sponsor: National Cancer Institute (NCI)
A 52-week Study of Remibrutinib in IgE-mediated Food Allergy
IgE-Mediated Food Allergy, Peanut Allergy
Phase 3
Interventional 576 participants sought
Asthma and Allergy Associates P C — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Novartis Pharmaceuticals
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Major Depressive Disorder
Phase 2
Interventional 164 participants sought
MCB Clinical Research Centers, Inc. — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Syndeio Biosciences, Inc
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Geographic Atrophy (GA), Age - Related Macular Degeneration (AMD)
Phase 2
Interventional 324 participants sought
Retina Consultants of Southern Colorado — Colorado Springs, Colorado (4.0 mi)
· Sponsor: ONL Therapeutics
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Penrose-Saint Francis Healthcare — Colorado Springs, Colorado (4.0 mi)
· Sponsor: SWOG Cancer Research Network
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 2,400 participants sought
Penrose-Saint Francis Healthcare — Colorado Springs, Colorado (4.0 mi)
· Sponsor: SWOG Cancer Research Network
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
Phase 3
Interventional 228 participants sought
UCHealth Memorial Hospital Central — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic
Phase 3
Interventional 680 participants sought
Rocky Mountain Cancer Centers LLP — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Pfizer